Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Margetuximab plus chemotherapy versus trastuzumab plus chemotherapy in previously treated HER2-positive metastatic breast cancer
CTR20200222Phase 2Active
- Sponsor
- Zai Lab
- Start
- Feb 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of margetuximab in breast cancer, sponsored by Zai Lab. Started Feb 2021; status: active.
02
Drugs
margetuximab
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20200222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200222.